Table 2.
Summary of significant BBT treatment and moderator effects.
| Clinical outcome (time in weeks) | Significant model effect | Significant effects for BBT compared to ARC within subgroup | ||||
|---|---|---|---|---|---|---|
| Main effect of tx | Tx × Dep × Trauma | Anx No trauma | Anx + Trauma | Anx/Dep No Trauma | Anx/Dep + Trauma | |
| CGI-I (16) | ✓ | ✓ | ✓ | ✓ | ✓ | ns |
| CGI-I (32) | ✓ | ns | ✓ | ✓ | ns | ns |
| CGAS (16) | ns | ✓ | ✓ | ✓ | ✓ | ns |
| CGAS (32) | ns | ✓ | ns | ✓ | ✓ | ns |
| PARS (16) | ✓ | ns | ✓ | ✓ | ns | ns |
| PARS (32) | ✓ | ✓ | ✓ | ✓ | ✓ | ns |
| CDRS (16) | ns | ✓ | ns | ✓ | ✓ | ns |
| CDRS (32) | ns | ✓ | ns | ns | ✓ | ns |
| Total number of significant effects | 4 | 6 | 5 | 7 | 6 | 0 |
Tx treatment, Dep comorbid clinically significant depression at baseline, Anx clinically significant anxiety at baseline, Trauma endorsed on KSADS, No Trauma no trauma endorsed on KSADS, CGI-I Clinical Global Impressions-Improvement, CGAS Children’s Global Adjustment Scale, PARS Pediatric Anxiety Rating Scale, CDRS-R Children’s Depression Rating Scale-Revised, ✓ statistically significant, ns non-significant.